LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...

The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants for children ages 7 months and older with bilateral sensorineural hearing ...

Ben Summers lights up with a smile the moment he talks about the “Batman” theme song or the afternoons he spends playing the piano at his grandmother’s house. Just a few years ago, Ben could not hear ...

Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...

An AI model using deep transfer learning—the most advanced form of machine learning—has predicted spoken language outcomes with 92% accuracy from one to three years after patients received cochlear ...

Thank you for standing by, and welcome to the Cochlear Limited FY '25 Results Analyst and Media Briefing. [Operator Instructions] I would now like to hand the conference over to Mr. Dig Howitt, CEO ...

The hearing implant pioneer has relieved investors with a full-year earnings result at the upper end of its revised guidance, saying adoption of its new high-tech product has been strong.

Hearing is one of those things most people never think about until it's gone. For millions living with severe to profound hearing loss, a cochlear implant isn't just a device. It's a way back to ...

During Better Hearing and Speech Month, understanding MRI compatibility is an important part of long-term hearing care LONE TREE, Colo., May 29, 2026 /PRNewswire/ -- May is Better Hearing and Speech ...